CVE-2010-3902

Description

OpenConnect before 2.26 places the webvpn cookie value in the debugging output, which might allow remote attackers to obtain sensitive information by reading this output, as demonstrated by output posted to the public openconnect-devel mailing list.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.56%
Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org Vendor Advisory fedoraproject.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://lists.fedoraproject.org/pipermail/package-announce/2010-November/051637.html vendor advisory
http://lists.fedoraproject.org/pipermail/package-announce/2010-November/051640.html vendor advisory
http://lists.fedoraproject.org/pipermail/package-announce/2010-November/051620.html vendor advisory
http://www.vupen.com/english/advisories/2010/3078 vdb entry
http://www.securityfocus.com/bid/44111 vdb entry
http://www.infradead.org/openconnect.html
http://secunia.com/advisories/42381 third party advisory

Frequently Asked Questions

What is the severity of CVE-2010-3902?
CVE-2010-3902 has been scored as a medium severity vulnerability.
How to fix CVE-2010-3902?
To fix CVE-2010-3902, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-3902 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2010-3902 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.